Dr Kylie Alexander

Dr Kylie Alexander is a Senior Research Officer and Mater Career Track Fellow.  

Dr Alexander completed her PhD at The University of Queensland (UQ) in 2010 and joined the Stem Cell Biology Research Group at Mater Research in 2016. She has a special interest in neurogenic heterotopic ossification (NHO), which causes debilitating bone growth around joints in patients with spinal cord injuries.  

Dr Alexander has authored 33 original research and review articles in impactful biomedical research journals including Cell Reports Medicine, Bone Research, and the Journal of Clinical Investigation, with more than 3,250 citations and a h-index of 21. Her work has attracted more than $4 million in funding from the NHMRC (in 2019 and 2024), The United States Department of Defence (2021), and a UQ ECR grant (2018).

Dr Alexander’s research vision is to understand the cellular mechanisms driving neurogenic heterotopic ossification with the hope to develop new prognostics and prophylactic treatments, which will reduce the need for invasive surgical resection of these pathological bones.